{"denoms":[{"counts":[{"groupId":"BG000","value":"240"}],"units":"Participants"}],"groups":[{"description":"6 once-weekly intravesical instillations of UGN-102 (75 mg mitomycin).","id":"BG000","title":"UGN-102"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"78"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"162"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"30","upperLimit":"92","value":"70"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"93"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"147"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"237"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"234"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"85"}]}],"title":"Bulgaria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"38"}]}],"title":"Latvia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"}]}],"title":"Georgia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}]}],"title":"Serbia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Estonia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Lithuania"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Austria"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"229"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"11"}],"title":"No"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Previous Low-grade Non-muscle Invasive Bladder Cancer (LG-NMIBC) Episode(s)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"124"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"116"}],"title":"No"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Previous LG-NMIBC Episode(s) Within 1 Year","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"228"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"12"}],"title":"No"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Prior Transurethral Resection of Bladder Tumor (TURBT) to Treat LG-NMIBC","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"216"}],"title":"≤ 3 cm"},{"measurements":[{"groupId":"BG000","value":"19"}],"title":"> 3 cm"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Missing"}]}],"description":"Longest tumor diameter is defined as the longest diameter among all measurable lesions.","paramType":"COUNT_OF_PARTICIPANTS","title":"Longest Tumor Diameter","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"180"}],"title":"≤ 3 cm"},{"measurements":[{"groupId":"BG000","value":"41"}],"title":"> 3 cm"},{"measurements":[{"groupId":"BG000","value":"19"}],"title":"Missing"}]}],"description":"Tumor burden is defined as the sum of the longest diameters of measurable lesions.","paramType":"COUNT_OF_PARTICIPANTS","title":"Tumor Burden","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"41"}],"title":"Single"},{"measurements":[{"groupId":"BG000","value":"198"}],"title":"Multiple"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Missing"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Tumor Count","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"112"}],"title":"Non-smoker"},{"measurements":[{"groupId":"BG000","value":"128"}],"title":"Smoker"}]}],"description":"Smoker category includes both former and current smokers. Non-smoker category includes \"Never.\"","paramType":"COUNT_OF_PARTICIPANTS","title":"Smoking History","unitOfMeasure":"Participants"}],"populationDescription":"All patients who received any dose of UGN-102."}